Macrophage Activation Marker Soluble CD163 Associated with Fatal and Severe Ebola Virus Disease in Humans1

Autor: Christina F. Spiropoulou, Jay B. Varkey, Bruce S. Ribner, G. Marshall Lyon, Jessica R. Harmon, Aneesh K. Mehta, Sherif R. Zaki, Timothy D. Flietstra, Punya Shrivastava-Ranjan, Luciana Silva-Flannery, Roosecelis B Martines, Colleen S. Kraft, Stuart T. Nichol, Anita K. McElroy
Rok vydání: 2019
Předmět:
Epidemiology
medicine.medical_treatment
medicine.disease_cause
Pathogenesis
Ebola virus
0302 clinical medicine
hyperferritinemia
Medicine
Macrophage
030212 general & internal medicine
Immunoassay
severe disease
Ebolavirus
3. Good health
Killer Cells
Natural

MAS
Infectious Diseases
Cytokine
Liver
Ebola
medicine.symptom
macrophage activation syndrome
HLH
Microbiology (medical)
hypertriglyceridemia
030231 tropical medicine
sCD163
T cells
Ebola virus disease
Antigens
Differentiation
Myelomonocytic

Receptors
Cell Surface

Inflammation
macrophage
sCD25
03 medical and health sciences
activation marker
Antigens
CD

Humans
viruses
Hemophagocytic lymphohistiocytosis
business.industry
Research
Macrophages
Hemorrhagic Fever
Ebola

Macrophage Activation
medicine.disease
zoonoses
hemophagocytic lymphohistiocytosis
inflammation
Macrophage Activation Marker Soluble CD163 Associated with Fatal and Severe Ebola Virus Disease in Humans
Macrophage activation syndrome
Immunology
CD163
business
Biomarkers
Zdroj: Emerging Infectious Diseases
ISSN: 1080-6059
1080-6040
Popis: Ebola virus disease (EVD) is associated with elevated cytokine levels, and hypercytokinemia is more pronounced in fatal cases. This type of hyperinflammatory state is reminiscent of 2 rheumatologic disorders known as macrophage activation syndrome and hemophagocytic lymphohistiocytosis, which are characterized by macrophage and T-cell activation. An evaluation of 2 cohorts of patients with EVD revealed that a marker of macrophage activation (sCD163) but not T-cell activation (sCD25) was associated with severe and fatal EVD. Furthermore, substantial immunoreactivity of host tissues to a CD163-specific antibody, predominantly in areas of extensive immunostaining for Ebola virus antigens, was observed in fatal cases. These data suggest that host macrophage activation contributes to EVD pathogenesis and that directed antiinflammatory therapies could be beneficial in the treatment of EVD.
Databáze: OpenAIRE